rome and Triple-Negative-Breast-Neoplasms

rome has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for rome and Triple-Negative-Breast-Neoplasms

Article	Year
Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl COVID-19 has been officially declared as a pandemic by the WHO. Italy was the first European country to be strongly affected by this outbreak. All elective and health promotion activities were reduced. Accordingly, Italian Breast Units and breast cancer (BC) screening programs scaled down significantly their activities. The aim of this study was to evaluate measures that could potentially reduce the clinical impact of COVID-19 on BC patients. Temporary recommendations are needed that could assist specialists in preventing COVID-19 infection and optimizing resources for diagnosis and treatment of BC patients. Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Coronavirus Infections; COVID-19; Delayed Diagnosis; Disease Management; Early Detection of Cancer; Elective Surgical Procedures; Estrogens; Female; Hospitals, University; Hospitals, Urban; Humans; Mammography; Mass Screening; Mastectomy; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Pandemics; Pneumonia, Viral; Rome; Treatment Refusal; Triple Negative Breast Neoplasms	2020

Article

Year

Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients.

In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl

COVID-19 has been officially declared as a pandemic by the WHO. Italy was the first European country to be strongly affected by this outbreak. All elective and health promotion activities were reduced. Accordingly, Italian Breast Units and breast cancer (BC) screening programs scaled down significantly their activities. The aim of this study was to evaluate measures that could potentially reduce the clinical impact of COVID-19 on BC patients. Temporary recommendations are needed that could assist specialists in preventing COVID-19 infection and optimizing resources for diagnosis and treatment of BC patients.

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Coronavirus Infections; COVID-19; Delayed Diagnosis; Disease Management; Early Detection of Cancer; Elective Surgical Procedures; Estrogens; Female; Hospitals, University; Hospitals, Urban; Humans; Mammography; Mass Screening; Mastectomy; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Pandemics; Pneumonia, Viral; Rome; Treatment Refusal; Triple Negative Breast Neoplasms

2020